SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq: ARTE), a medical technology company whose product ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of “smile line” wrinkles, today reported financial results for the three and nine months ended September 30, 2007.
The Company also announced a number of significant strategic initiatives intended to significantly expand the Company’s sales force, the number of physicians trained on the use of ArteFill, and additional programs to increase awareness and demand from consumers.
